The peroxisome proliferator-activated receptor-gamma (PPARy) agonist, pioglitazone, belongs to the insulin-sensitizing group of drugs, which is used in the treatment of type 2 diabetes mellitus (T2DM) [3]. The gene discussed is PPARG; the disease is type 2 diabetes mellitus.